Lepzacitinib
Product Specifications
CAS Number
2321488-47-3
Target
JAK
Related Pathways
Stem Cells, JAK/STAT signaling, Angiogenesis, Chromatin/Epigenetic, Tyrosine Kinase/Adaptors
Purity
0.9985
Bioactivity
Lepzacitinib is a selective, small molecule JAK1/3 inhibitor used for the treatment of atopic dermatitis and other skin diseases. As a Janus kinase inhibitor, it reduces the inflammatory response.
Smiles
N(C1=C2C(=NC=C1C(OCC)=O)NC=C2)[C@H]3CN(C(CC#N)=O)CCC3
Molecular Formula
C18H21N5O3
Molecular Weight
355.39
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1375984-01 0.02 mg (E-Coli)
Recombinant Saccharophagus degradans Aspartate carbamoyltransferase (pyrB)
Sign In for Pricing
View Details 
MBS1375984-02 0.02 mg (Yeast)
Recombinant Saccharophagus degradans Aspartate carbamoyltransferase (pyrB)
Sign In for Pricing
View Details MBS1375984-03 0.1 mg (E-Coli)
Recombinant Saccharophagus degradans Aspartate carbamoyltransferase (pyrB)
Sign In for Pricing
View Details 
MBS1375984-04 0.1 mg (Yeast)
Recombinant Saccharophagus degradans Aspartate carbamoyltransferase (pyrB)
Sign In for Pricing
View Details MBS1375984-05 0.02 mg (Baculovirus)
Recombinant Saccharophagus degradans Aspartate carbamoyltransferase (pyrB)
Sign In for Pricing
View Details MBS1375984-06 0.02 mg (Mammalian-Cell)
Recombinant Saccharophagus degradans Aspartate carbamoyltransferase (pyrB)
Sign In for Pricing
View Details